HUYABIO International
Peter Stiegler is a highly experienced professional in the field of clinical operations with a focus on oncology studies. With a background that includes roles at prominent companies such as HUYABIO International, Capricor Therapeutics, Progenity Inc., and Novartis, Peter has held various leadership titles throughout their career. Stiegler's educational background includes earning an MSc and PhD in Life Science with a specialization in Oncology from the University of Vienna.
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.